{
Vesalius Therapeutics

Companies

}
001122334455554433221100
001122334455554433221100

gsk partners with vesalius therapeutics to advance parkinsons drug development

GSK Plc has entered a partnership with US biotech Vesalius Therapeutics, valued at up to $650 million, to advance drug development for Parkinson’s disease. The agreement includes an $80 million upfront payment, with the potential for an additional $570 million for full development and commercialization rights to Vesalius’s early-stage drug program.
bloomberg.com
United States Dollar Vesalius Therapeutics GSK plc GBR
Healthcare, Press Release
12:32 12.11.2024
Trending
Subcategory
Corporate News Industry Trends Stock Market Updates Retail and Consumer Goods Finance Mergers & Acquisitions Global Financial Events Global Trade Developments Industry Mergers & Acquisitions Banking Regulations CEO Changes Market Analysis and Predictions Supply Chain Management Central Bank Actions Workplace Trends Government Economic Policies Startups & Entrepreneurship Hedge Funds & Private Equity Financial Scams and Security Government Policies Domestic Politics
Countries:
USA CHN CHE FRA DEU IND GBR AUT ITA RUS JPN CAN ARE UKR SGP HKG MEX IDN BRA VNM
Companies:
Barclays PLC BNP Paribas SA Tesla, Inc. Deutsche Bank RV Global PP Apple Inc. Raiffeisen Bank International AG JPMorgan Chase & Co. Citigroup Inc. UniCredit S.p.A. The Goldman Sachs Group, Inc. Strabag SE UBS Group AG Bank of America Corporation Google Inc. Morgan Stanley Kering S.A. (ADRs) NVIDIA Corporation Microsoft Corporation Lloyds Banking Group plc Banco BPM S.p.A.
Currencies:
United States Dollar Euro Chinese Yuan British Pound Sterling Swiss Franc Indian Rupee Japanese Yen Vietnamese Đồng Russian Ruble Hong Kong Dollar United Arab Emirates Dirham Australian Dollar Indonesian Rupiah Brazilian Real Canadian Dollar Filipino Peso Malaysian Ringgit South African Rand South Korean Won Offshore Chinese Yuan
People:
Donald Trump Elon Musk Jean-Laurent Bonnafé Warren Buffett Oleg Deripaska Armin Brun Joe Guccione Joe Biden Jerome Powell Scott Bessent Andrea Casati Jason Stephenson Michael Lundon Kelvin Taylor Nguyen Duc Vinh Andreas Schneemann Eva Fugger Susy Tibaldi Karoline Leavitt Tim Baker

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.